AllanPantuckMD

Urology • Los Angeles, CA

Associate Professor, Urology, UCLA School of Medicine

Join to view full profile

Dr. Pantuck is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Pantuck's full profile

Already have an account?

Office
UCLA Medical Center
10833 LeConte Ave, 66-128 CHS
Los Angeles, CA 90095
Phone+1 310-206-2436

Fax+1 310-206-2436
Is this information wrong?

Education & Training

Rutgers Robert Wood Johnson Medical SchoolResidency, Urology, 1995 - 1999
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 1993 - 1995
Rutgers Robert Wood Johnson Medical SchoolClass of 1993

Certifications & Licensure

CA State Medical License 1999 - 2025
FL State Medical License 2017 - 2019
NJ State Medical License 1995 - 1999
American Board of Urology Urology

Awards, Honors, & Recognition

Fellow (FACS) American College of Surgeons

Clinical Trials

Biological Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2002 Mar 01
Completed
Phase 1
Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer Start of enrollment: 2004 Nov 30
Completed
Not Applicable
Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer Start of enrollment: 2004 May 01
Completed
Phase 2
Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection Start of enrollment: 2005 Aug 01
Completed
Not Applicable
Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer Start of enrollment: 2005 Nov 01
Completed
Not Applicable
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy Start of enrollment: 2009 Feb 01
Completed
Not Applicable
Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer Start of enrollment: 2008 Feb 01
Unknown status
Phase 2
Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer Start of enrollment: 2007 Dec 01
Unknown status
Phase 2
A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial) Start of enrollment: 2008 Jul 01
Active, not recruiting
Not Applicable
Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c) Start of enrollment: 2011 Jan 01
Completed
Phase 3
MCS in the Treatment of Lower Urinary Tract Symptoms Start of enrollment: 2010 Jul 01
Completed
Phase 2, Phase 3
Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer Start of enrollment: 2013 Aug 22
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Gain of Chromosome 5q Predicts a Favorable Prognosis in Localized Renal Cell Carcinoma.
Cedric Lebacle, Aydin Pooli, Brian Shuch, Nagesh Rao, Karim Chamie, Nils Kroeger, Izak Faiena, Sandy Liu, Erika L Wood, Arie Belldegrun, Alexandra Drakaki, Allan J Pan...> ;Cancer Investigation. 2024 Jan 1
1 citations
CD70 is Consistently Expressed in Primary and Metastatic Clear Cell Renal Cell Carcinoma.
Rong Rong Huang, Zhengshan Chen, Nils Kroeger, Allan Pantuck, Jonathan Said, Harriet M Kluger, Brian Shuch, Huihui Ye> ;Clinical Genitourinary Cancer. 2024 Apr 1
1 citations
Do Cancer Genetics Impact Treatment Decision Making? Immunotherapy and Beyond in the Management of Advanced and Metastatic Urothelial Carcinoma.
Gavin Hui, Dimitrios Stefanoudakis, Yuliya Zektser, Dayna Jill Isaacs, Christopher Hannigan, Allan J Pantuck, Alexandra Drakaki> ;Current Oncology. 2023 Aug 4
4 citations
The Potential Revolution of Cancer Treatment with CRISPR Technology.
Dimitrios Stefanoudakis, Nikhita Kathuria-Prakash, Alexander W Sun, Melissa Abel, Claire E Drolen, Camille Ashbaugh, Shiliang Zhang, Gavin Hui, Yeganeh A Tabatabaei, Y...> ;Cancers. 2023 Mar 17
Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate-risk clear cell kidney cancer.
Alexander Hakansson, Shinji Ohtake, Peter Muraki, James A Proudfout, Yang Liu, Lisa Webber, Arkaitz Ibarra, Vinnie Y T Liu, Elai Davicioni, Karim Chamie, Allan Pantuck...> ;Cancer Medicine. 2023 Mar 1
16 citations
MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study.
Behfar Ehdaie, Clare M Tempany, Ford Holland, Daniel D Sjoberg, Adam S Kibel, Quoc-Dien Trinh, Jeremy C Durack, Oguz Akin, Andrew J Vickers, Peter T Scardino, Dan Sper...> ;The Lancet. Oncology. 2022 Jul 1
Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cel...
Nils Kroeger, Cédric Lebacle, Justine Hein, P N Rao, Reza Nejati, Shuanzeng Wei, Martin Burchardt, Alexandra Drakaki, Marshall Strother, Alexander Kutikov, Robert Uzzo...> ;European Journal of Cancer. 2022 Jun 1
9 citations
A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Ca...
Debashis Sarker, Nancy A. Dawson, Ana Aparicio, Tanya B. Dorff, Allan J. Pantuck, Ulka N. Vaishampayan, Lynn Henson, Lakshmi Vasist, Sumita Roy-Ghanta, Michele Gorczyc...> ;Clinical Cancer Research. 2021 Oct 1
24 citations
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer
Laurence Klotz, Christian P. Pavlovich, Joseph L. Chin, Gencay Hatiboglu, Michael O. Koch, David F. Penson, Steven Raman, Aytekin Oto, Jurgen J. Fütterer, Marc Serrall...> ;The Journal of Urology. 2021 Mar 1
Reply by Authors.
Laurence Klotz, Christian P Pavlovich, Joseph Chin, Gencay Hatiboglu, Michael Koch, David Penson, Steven Raman, Aytekin Oto, Jurgen Fütterer, Marc Serrallach, James Re...> ;The Journal of Urology. 2021 Mar 1
2 citations
Exploratory analysis of the platelet-to-lymphocyte ratio prognostic value in the adjuvant renal cell cancer setting.
Anup Patel, Alain Ravaud, Robert J. Motzer, Allan J. Pantuck, Michael Staehler, Bernard Escudier, Jean-Francois Martini, Mariajose Lechuga, Xun Lin, Daniel J. George> ;Future Oncology. 2021 Feb 1
8 citations
"Real-world" outcomes and prognostic indicators among patients with high-risk muscle-invasive urothelial carcinoma.
Alexandra Drakaki, Allan J. Pantuck, Shivani K. Mhatre, Preet K. Dhillon, Nicole N. Davarpanah, Viraj Degaonkar, Andy Surinach, Karim Chamie, Petros Grivas> ;Urologic Oncology. 2021 Jan 1
9 citations
A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC...
Izak Faiena, Begoña Comin-Anduix, Beata Berent-Maoz, Adrian Bot, Nazy Zomorodian, Ankush Sachdeva, Jonathan W. Said, Gardenia Cheung-Lau, Jia Pang, Mignonette H. Macab...> ;Journal of Immunotherapy. 2020 Nov 1
8 citations
Association of tumor grade, enhancement on multiphasic CT and microvessel density in patients with clear cell renal cell carcinoma
Heidi Coy, Jonathan R. Young, Allan J. Pantuck, Michael Douek, Anthony Sisk, Clara E. Magyar, Matthew S. Brown, James Sayre, Steven S. Raman> ;Abdominal Radiology. 2020 Oct 1
54 citations
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
Rahul Aggarwal, Michael T. Schweizer, David M. Nanus, Allan J. Pantuck, Elisabeth I. Heath, Eric Campeau, Sarah Attwell, Karen Norek, Margo Snyder, Lisa Bauman, Sanjay...> ;Clinical Cancer Research. 2020 Jul 21
15 citations
Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC T...
Anup Patel, Alain Ravaud, Robert J. Motzer, Allan J. Pantuck, Michael Staehler, Bernard Escudier, Jean-Francois Martini, Mariajose Lechuga, Xun Lin, Daniel J. George> ;Clinical Cancer Research. 2020 Jun 16
4 citations
Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients
Johannes Heide, Silvia Ribback, Tobias Klatte, Shahrokh F. Shariat, Martin Burchardt, Frank Dombrowski, Arie S. Belldegrun, Alexandra Drakaki, Allan J. Pantuck, Nils K...> ;World Journal of Urology. 2020 Jun 1
7 citations
Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors
Aydin Pooli, Amirali Salmasi, David W. Johnson, Andrew T. Lenis, Izak Faiena, Cedric Lebacle, Vishnukamal Golla, Alexandra Drakaki, Kiran Gollapudi, Jeremy Blumberg, A...> ;Urologic Oncology. 2020 Jan 1
9 citations
Long-Term Survival after Percutaneous Radiofrequency Ablation of Pathologically Proven Renal Cell Carcinoma in 100 Patients.
Harry Marshall, Sepideh Shakeri, Melina Hosseiny, Anthony Sisk, James Sayre, David S.K. Lu, Allan J. Pantuck, Steven S. Raman> ;Journal of Vascular and Interventional Radiology. 2020 Jan 1
168 citations
The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC).
Brian I. Rini, Dena Battle, Robert A. Figlin, Daniel J. George, Hans J. Hammers, Thomas E. Hutson, Eric Jonasch, Richard W. Joseph, David F. McDermott, Robert J. Motze...> ;Journal for Immunotherapy of Cancer. 2019 Dec 20
29 citations
The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASS...
Tobias Klatte, Kevin M Gallagher, Luca Afferi, Alessandro Volpe, Nils Kroeger, Silvia Ribback, Alan McNeill, Antony C. P. Riddick, James N. Armitage, Tevita Aho, Tim E...> ;BMC Medicine. 2019 Oct 3
14 citations
Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluati...
Alexander Upfill-Brown, Andrew T. Lenis, Izak Faiena, Amirali Salmasi, David W. Johnson, Aydin Pooli, Alexandra Drakaki, Kiran Gollapudi, Jeremy Blumberg, Allan J. Pan...> ;World Journal of Urology. 2019 Jun 1
16 citations
Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival.
Andrew T. Lenis, Claire S. Burton, Vishnukamal Golla, Aydin Pooli, Izak Faiena, David W. Johnson, Amirali Salmasi, Alexandra Drakaki, Kiran Gollapudi, Jeremy Blumberg,...> ;Urologic Oncology. 2019 Mar 28
12 citations
The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas.
Sepideh Shakeri, Sohrab Afshari Mirak, Amirhossein Mohammadian Bajgiran, Allan J. Pantuck, Anthony Sisk, Preeti Ahuja, David S.K. Lu, Steven S. Raman> ;Abdominal Radiology. 2019 Mar 7
3 citations
Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma
Izak Faiena, Stephanie H. Astrow, David Elashoff, Rajul K. Jain, Adrian Bot, Karim Chamie, Arie S. Belldegrun, Allan J. Pantuck, Alexandra Drakaki> ;Cancer Immunology, Immunotherapy. 2019 Feb 21
Join now to see all

Other

Surveillance for metastatic disease after nephrectomy for renal cell carcinoma
Pantuck AJ, Shuch B, Klatte T
http://www.uptodate.com/contents/surveillance-for-metastatic-disease-after-nephrectomy-for-renal-cel
UpToDate, Wolters Kluwer Health - 2012-08-16

Authored Content

Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018
Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018

Press Mentions

Athos Therapeutics Receives Regulatory Approval to Commence Phase I Clinical Trial of ATH-063March 29th, 2023
Abraham Verghese MD, Noted Stanford Physician and Recipient of the National Humanities Medal at the White House from Former President Obama, Appointed to the Board of Directors of Athos TherapeuticsMay 18th, 2022
UCLA Researchers to Present on Latest Research and Clinical Advancements at American Urological Association Annual MeetingAugust 26th, 2021
Join now to see all